Effects of Whole Grain Rye on Metabolic Risk Markers and Mood
Not Applicable
Completed
- Conditions
- Metabolic Disorders and Cognitive Decline
- Registration Number
- NCT03275948
- Lead Sponsor
- Lund University
- Brief Summary
The purpose of the study is to investigate, in healthy middle age subjects, effects of whole grain rye on cognitive functions, mood, and cardiovasculair risk markers
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 38
Inclusion Criteria
- healthy
- BMI 19-28
- plasma glucose < 6.1 mmol/L
- non smooker
Exclusion Criteria
- known metabolic diseases
- known gastrointestinal disorders
- known cognitive decline.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- CROSSOVER
- Primary Outcome Measures
Name Time Method cognitive performance postprandial 0-180 min after breakfast test of working memory capacity
- Secondary Outcome Measures
Name Time Method glucose tolerance 0-180 min after breakfast postprandial glucose concentrations
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms link whole grain rye consumption to improved cardiometabolic risk markers in NCT03275948?
How does whole grain rye compare to refined wheat in modulating insulin resistance and cognitive performance in middle-aged adults?
Which biomarkers correlate with mood enhancement and metabolic improvements in NCT03275948's rye intervention?
What adverse events were observed in NCT03275948's whole grain rye trial, and how do they compare to other dietary interventions for metabolic disorders?
Are there synergistic effects of combining whole grain rye with probiotics or fiber supplements on metabolic and cognitive outcomes in Lund University studies?